ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

International PCNSL Collaborative Group (IPCG) consensus guidelines for the assessment of response in PCNSL

International PCNSL Collaborative Group (IPCG) consensus guidelines for the assessment of response in PCNSL
Response Brain imaging Steroid dose Ophthalmologic examination CSF cytology
Complete response (CR) No contrast-enhancing disease None Normal Negative
Unconfirmed complete response (uCR) No contrast-enhancing disease Any Normal Negative
Minimal enhancing disease Any Minor RPE abnormality Negative
Partial response (PR) 50% decrease in enhancement NA Normal or minor RPE abnormality Negative
No contrast-enhancing disease NA Decrease in vitreous cells or retinal infiltrate Persistent or suspicious
Progressive disease (PD)

25% increase in enhancing disease

Any new site of disease		 NA Recurrent or new disease Recurrent or positive
Stable disease (SD) Less than PR but not PD      
CSF: cerebrospinal fluid; NA: not applicable; PCNSL: primary central nervous system lymphoma; RPE: retinal pigment epithelium.
Adapted with permission from: Abrey LE, Batchelor TT, Ferreri AJM, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005; 23(22):5034-5043. Copyright © 2005 American Society of Clinical Oncology. https://ascopubs.org/journal/jco.
Graphic 139964 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟